ROYAL BANK OF CANADA - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 149 filers reported holding AMICUS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,446,000
+8.8%
283,400
+12.4%
0.00%0.0%
Q2 2023$3,168,000
+8.2%
252,174
-4.6%
0.00%0.0%
Q1 2023$2,929,000
-15.9%
264,202
-7.4%
0.00%0.0%
Q4 2022$3,483,000
+71.6%
285,335
+46.8%
0.00%0.0%
Q3 2022$2,030,000
+0.1%
194,366
+3.0%
0.00%0.0%
Q2 2022$2,027,000
+15.8%
188,782
+2.2%
0.00%
Q1 2022$1,750,000
-25.8%
184,769
-9.5%
0.00%
-100.0%
Q4 2021$2,357,000
+55.9%
204,106
+29.0%
0.00%
Q3 2021$1,512,000
+7.0%
158,227
+8.0%
0.00%
Q2 2021$1,413,000
+3.1%
146,570
+5.6%
0.00%
Q1 2021$1,370,000
+113.4%
138,772
+400.0%
0.00%
Q4 2020$642,000
+88.3%
27,755
+14.8%
0.00%
Q3 2020$341,000
+79.5%
24,183
+92.1%
0.00%
Q2 2020$190,000
-35.6%
12,588
-60.5%
0.00%
Q1 2020$295,000
-76.4%
31,884
-75.1%
0.00%
Q4 2019$1,248,000
+20.9%
128,194
-0.4%
0.00%
Q3 2019$1,032,000
-33.2%
128,755
+4.0%
0.00%
-100.0%
Q2 2019$1,545,000
-12.8%
123,819
-5.0%
0.00%0.0%
Q1 2019$1,772,000
-64.0%
130,301
-74.6%
0.00%
-50.0%
Q4 2018$4,920,000
-7.4%
513,566
+16.9%
0.00%0.0%
Q3 2018$5,311,000
+3.6%
439,300
+33.8%
0.00%0.0%
Q2 2018$5,128,000
+6.9%
328,265
+2.9%
0.00%0.0%
Q1 2018$4,796,000
-29.2%
318,869
-32.3%
0.00%
-33.3%
Q4 2017$6,777,000
-8.0%
471,009
-3.6%
0.00%
-25.0%
Q3 2017$7,368,000
-21.1%
488,576
-47.3%
0.00%
-20.0%
Q2 2017$9,333,000
+41.3%
926,796
+0.0%
0.01%
+25.0%
Q1 2017$6,605,000
+11487.7%
926,546
+8030.4%
0.00%
Q4 2016$57,000
+147.8%
11,396
+261.5%
0.00%
Q3 2016$23,000
+2200.0%
3,152
+3052.0%
0.00%
Q2 2016$1,000
-97.9%
100
-97.1%
0.00%
Q3 2015$47,000
-93.2%
3,422
-93.0%
0.00%
Q2 2015$696,000
+5253.8%
49,200
+4000.0%
0.00%
Q1 2015$13,000
+1200.0%
1,200
+117.4%
0.00%
Q3 2013$1,0005520.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,114,043$116,817,0007.46%
Parametrica Management Ltd 597,279$6,899,0006.86%
Redmile Group, LLC 22,716,086$262,371,0005.96%
Perceptive Advisors 53,118,886$613,524,0004.73%
Asymmetry Capital Management, L.P. 716,709$8,278,0004.39%
CM Management, LLC 450,000$5,198,0003.93%
Avoro Capital Advisors LLC 18,500,000$213,675,0003.64%
Kynam Capital Management, LP 573,699$6,626,0003.54%
SECTORAL ASSET MANAGEMENT INC 1,242,882$14,355,0002.16%
Ghost Tree Capital, LLC 500,000$5,775,0002.07%
View complete list of AMICUS THERAPEUTICS INC shareholders